Jan. 19, 2022
Previous Next

COVID-19 R&D: Computing responds to pandemic

Holly Auten/LLNL

When the COVID-19 pandemic began, the Laboratory immediately started seeking solutions to the myriad challenges posed by the global crisis. The Computing Directorate jumped right in with research and development activities that combine molecular screening to inform antiviral drug experimentation; a generative molecular design software platform to optimize properties of antiviral drugs; an online portal housing predicted viral protein–drug interactions and other data; and processor, memory, and storage upgrades to the computing systems that power these projects. Read more at LLNL Computing.